Beata Lihammar - Episurf Medical Principal Auditor

All Insiders . Sweden . 
Stock . Episurf Medical AB . Stakeholders . Insider . Beata Lihammar
EPIS-B Stock  SEK 0.13  0.01  8.33%   

Insider

Beata Lihammar is Principal Auditor of Episurf Medical AB
Phone46 86 12 00 20
Webhttps://episurf.com

Episurf Medical Management Efficiency

The company has return on total asset (ROA) of (0.2577) % which means that it has lost $0.2577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4506) %, meaning that it generated substantial loss on money invested by shareholders. Episurf Medical's management efficiency ratios could be used to measure how well Episurf Medical manages its routine affairs as well as how well it operates its assets and liabilities.
Episurf Medical AB has accumulated 800 K in total debt with debt to equity ratio (D/E) of 8.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Episurf Medical AB has a current ratio of 5.66, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Episurf Medical until it has trouble settling it off, either with new capital or with free cash flow. So, Episurf Medical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Episurf Medical AB sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Episurf to invest in growth at high rates of return. When we think about Episurf Medical's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Thoas MDCantargia AB
61
AnnMarie ThorBonesupport Holding AB
N/A
David VikstrmXbrane Biopharma AB
46
Fergus MacLeodBonesupport Holding AB
53
Kristina IngvarBonesupport Holding AB
51
Sathish SubramaniamBactiguard Holding AB
44
Peter MadsenCantargia AB
N/A
Dominique TersagoCantargia AB
61
Nina IversXbrane Biopharma AB
53
Ignacio GarciaRibasCantargia AB
N/A
Maria EdebrinkXbrane Biopharma AB
54
Stefan MBABioInvent International AB
60
Carin JakobsonBactiguard Holding AB
49
Ingrid TeigeBioInvent International AB
N/A
Bjrn FrendusBioInvent International AB
50
Peter RadqvistBactiguard Holding AB
56
Carl FredinBactiguard Holding AB
57
RGN MScBioInvent International AB
N/A
Anette LindqvistXbrane Biopharma AB
57
Samuel WagnerXbrane Biopharma AB
N/A
Susanne LagerlundCantargia AB
N/A
Episurf Medical AB , a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Benelux, Germany, and the United Kingdom. Episurf Medical AB was founded in 2008 and is headquartered in Stockholm, Sweden. Episurf Medical is traded on Stockholm Stock Exchange in Sweden. Episurf Medical AB (EPIS-B) is traded on Stockholm Exchange in Sweden and employs 31 people.

Management Performance

Return On Equity-0.45
Return On Asset-0.26

Episurf Medical AB Leadership Team

Elected by the shareholders, the Episurf Medical's board of directors comprises two types of representatives: Episurf Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Episurf. The board's role is to monitor Episurf Medical's management team and ensure that shareholders' interests are well served. Episurf Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Episurf Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Veronica Wallin, Chief Officer
Katarina Flodstrm, Chief Officer
Michael Nsstrm, Head Affairs
Beata Lihammar, Principal Auditor
Pal Ryfors, Chief Officer
Stephen Caswell, Head OUS
Fredrik Zetterberg, Marketing Director
Patrick Jamnik, President

Episurf Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Episurf Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.45
Return On Asset-0.26
Operating Margin(11.71) %
Current Valuation291.48 M
Shares Outstanding266.43 M
Shares Owned By Insiders21.11 %
Shares Owned By Institutions12.17 %
Price To Earning(2.21) X
Price To Book2.31 X
Price To Sales74.39 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Other Information on Investing in Episurf Stock

Episurf Medical financial ratios help investors to determine whether Episurf Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Episurf with respect to the benefits of owning Episurf Medical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY